Alan Bash - Mar 1, 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Chief Executive Officer, Director
Signature
/s/ Kleem Chaudhary, Attorney-in-Fact
Stock symbol
CMPI
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 03:10 PM
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +575K $0.00 575K Mar 1, 2022 Common Stock 575K $2.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 25% on the first anniversary of the grant date and in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continued service through such date.